Human Papilloma Virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada

被引:77
|
作者
Sauvageau, Chantal [1 ,3 ,4 ]
Duval, Bernard [2 ,3 ,4 ]
Gilca, Vladimir [2 ,3 ]
Lavoie, France [3 ]
Ouakki, Manale [3 ]
机构
[1] Hlth & Social Serv Agcy, Quebec Reg Publ Hlth Dept, Quebec City, PQ, Canada
[2] Quebec Inst Publ Hlth, Quebec City, PQ, Canada
[3] Univ Laval, Ctr Hosp, Publ Hlth Res Ctr, Quebec City, PQ, Canada
[4] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada
关键词
D O I
10.1186/1471-2458-7-304
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The Pap test has been used for cervical cancer screening for more than four decades. A human papillomavirus (HPV) vaccine has been approved for use in Canada and is commercially available now. These two preventive interventions should be considered simultaneously. General population support is an important factor for the successful combination of these interventions. The study had two objectives: 1) To assess practices, beliefs, and attitudes regarding Pap test screening and HPV immunization; 2) To identify socio-demographic factors for Pap screening and vaccine acceptability. Methods: In 2006, 500 adults were invited to participate in a telephone survey in the region of Quebec City (urban and rural population, 600 000), Canada. Some neutral and standardized information on Pap test and HPV was provided before soliciting opinions. Results: 471 adults (18-69 year-olds) answered the questionnaire, the mean age was 45 years, 67% were female, and 65% had college or university degree. Eighty- six percent of women had undergone at least one Pap-test in their life, 55% in the last year, and 15% from 1 to 3 years ago. Among screened women, the test had been performed in the last three years in 100% of 18 - 30 year- olds, but only in 67% of 60-69 year-olds (P < 0.0001). Only 15% of respondents had heard of HPV. Eighty- seven percent agreed that HPV vaccines could prevent cervical cancer, 73% that the vaccine has to be administered before the onset of sexual activity, 89% would recommend vaccination to their daughters and nieces. Among respondents < 25 years, 91% would agree to receive the vaccine if it is publicly funded, but only 72% would agree to pay $ 100/dose. Conclusion: There is an important heterogeneity in cervical cancer screening frequency and coverage. Despite low awareness of HPV infection, the majority of respondents would recommend or are ready to receive the HPV vaccine, but the cost could prevent its acceptability.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Human Papilloma Virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada
    Chantal Sauvageau
    Bernard Duval
    Vladimir Gilca
    France Lavoie
    Manale Ouakki
    [J]. BMC Public Health, 7
  • [2] Acceptability of Human Papilloma Virus Self-testing for Cervical Cancer Screening
    Postlethwaite, Debbie
    Livingston, Julie
    Merchant, Maqdooda
    Hebl, Sarah
    Armstrong, Mary Anne
    [J]. JOURNAL OF WOMENS HEALTH, 2015, 24 (04) : 36 - 36
  • [3] Acceptability of human papilloma virus vaccine and cervical cancer screening among female health-care workers in Enugu, Southeast Nigeria
    Ugwu, E. O.
    Obi, S. N.
    Ezechukwu, P. C.
    Okafor, I. I.
    Ugwu, A. O.
    [J]. NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2013, 16 (02) : 249 - 252
  • [4] Acceptability and Feasibility of Human Papilloma Virus Self-Sampling for Cervical Cancer Screening
    Ilangovan, Kumar
    Kobetz, Erin
    Koru-Sengul, Tulay
    Marcus, Erin N.
    Rodriguez, Brendaly
    Alonzo, Yisel
    Carrasquillo, Olveen
    [J]. JOURNAL OF WOMENS HEALTH, 2016, 25 (09) : 944 - 951
  • [5] Cervical Cancer Prevention in the Human Papilloma Virus Vaccine Era
    Ghazal-Aswad, Saad
    [J]. RECENT ADVANCES IN CLINICAL ONCOLOGY, 2008, 1138 : 253 - 256
  • [6] DETERMINANTS OF HUMAN PAPILLOMA VIRUS VACCINATION (HPVV) AMONG QUEBEC (CANADA) TEENAGERS
    Guay, M.
    Clement, P.
    Hamid, A.
    Dube, E.
    Sauvageau, C.
    Boulianne, N.
    Landry, M.
    Lemaire, J.
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2011, 87 : A213 - A213
  • [7] Human papilloma virus and cervical screening
    Damasus-Awatai, G
    Freeman-Wang, T
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2003, 15 (06) : 473 - 477
  • [8] Screening for Cervical Cancer and Human Papilloma Virus Indian Context
    Deodhar, Kedar K.
    [J]. CLINICS IN LABORATORY MEDICINE, 2012, 32 (02) : 193 - +
  • [9] Acceptability of human papilloma virus vaccine: parent survey
    Baddouh, Naima
    Rada, Noureddine
    Elalouani, Fatima Ezzahra
    Draiss, Ghizlane
    Bouskraoui, Mohammed
    [J]. PAN AFRICAN MEDICAL JOURNAL, 2018, 31
  • [10] Human papilloma virus (HPV) vaccine and cervical cancer prevention in Africa
    Okonofua, Friday
    Edouard, Lindsay
    Isikhuemen, Maradona
    [J]. AFRICAN JOURNAL OF REPRODUCTIVE HEALTH, 2023, 27 (12): : 9 - 14